| scholarly article | Q13442814 |
| P2093 | author name string | Donald T Lysle | |
| Stephanie G Ijames | |||
| Kelly A Carrigan | |||
| Timothy B Saurer | |||
| P2860 | cites work | Specificity in the projection patterns of accumbal core and shell in the rat. | Q30451154 |
| Behaviorally conditioned immunosuppression | Q33955422 | ||
| Dopamine and drug addiction: the nucleus accumbens shell connection. | Q34355473 | ||
| Mesolimbic dopaminergic pathways in fear conditioning | Q34373980 | ||
| Noradrenergic and peptidergic innervation of lymphoid tissue | Q34682207 | ||
| Involvement of brain opiate receptors in the immune-suppressive effect of morphine. | Q37400257 | ||
| Immunomodulation by behavioural conditioning | Q38694327 | ||
| BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological properties | Q41171369 | ||
| Effect of neuropeptide Y on natural killer activity of normal human lymphocytes | Q41568705 | ||
| Molecular cloning of NPY-Y1 receptor cDNA from rat splenic lymphocytes: evidence of low levels of mRNA expression and [125I]NPY binding sites | Q42492003 | ||
| Involvement of opioid mu 1 receptors in morphine-induced conditioned place preference in rats | Q42548125 | ||
| Selective responding of nucleus accumbens core and shell dopamine to aversively conditioned contextual and discrete stimuli | Q43818706 | ||
| Evidence for the involvement of beta-adrenergic receptors in conditioned immunomodulation | Q44187665 | ||
| NPY modulates epinephrine-induced leukocytosis via Y-1 and Y-5 receptor activation in vivo: sympathetic co-transmission during leukocyte mobilization | Q44205686 | ||
| Naloxone antagonism of conditioned hyperthermia: An evidence for release of endogenous opioid | Q44330593 | ||
| Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity | Q44331230 | ||
| Pavlovian conditioning of morphine-induced alterations of immune status: evidence for opioid receptor involvement | Q44335634 | ||
| Alpha adrenergic and mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity. | Q44339859 | ||
| Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats. | Q44341702 | ||
| Conditioned immunomodulation: investigations of the role of endogenous activity at mu, kappa, and delta opioid receptor subtypes | Q44347475 | ||
| Dopamine efflux in nucleus accumbens shell and core in response to appetitive classical conditioning | Q44574122 | ||
| Conditioning of morphine-induced taste aversion and analgesia | Q44605683 | ||
| Conditioned immunosuppression of a murine delayed type hypersensitivity response: dissociation from corticosterone elevation | Q44748540 | ||
| Sympathetic nervous system mediates central corticotropin-releasing factor induced suppression of natural killer cytotoxicity | Q46070203 | ||
| Suppression of natural killer cell cytotoxicity following chronic electrical stimulation of the ventromedial hypothalamic nucleus in rats | Q46483208 | ||
| Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell | Q46858852 | ||
| Behaviorally conditioned immunosuppression using cyclosporine A: central nervous system reduces IL-2 production via splenic innervation | Q47750819 | ||
| Chronic electrical stimulation of the lateral hypothalamus increases natural killer cell cytotoxicity in rats | Q48202232 | ||
| Efferent projections of the nucleus accumbens in the rat with special reference to subdivision of the nucleus: biotinylated dextran amine study | Q48447004 | ||
| Modulation of immune status by a conditioned aversive stimulus: evidence for the involvement of endogenous opioids | Q48477893 | ||
| Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity | Q48501860 | ||
| Suppression of the development of adjuvant arthritis by a conditioned aversive stimulus | Q48524420 | ||
| Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats | Q48985659 | ||
| Shock-induced modulation of lymphocyte responsiveness and natural killer activity: differential mechanisms of induction. | Q51771629 | ||
| Conditioned effects of heroin on the expression of inducible nitric oxide synthase in the rat are susceptible to extinction and latent inhibition. | Q51997373 | ||
| Pavlovian conditioning of morphine-induced alterations of immune status: evidence for peripheral beta-adrenergic receptor involvement. | Q52214792 | ||
| Pavlovian conditioning of morphine-induced alterations of immune status. | Q52230393 | ||
| Pavlovian conditioning of immunosuppression modifies adjuvant arthritis in rats. | Q52280314 | ||
| Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus. | Q52288783 | ||
| Adrenal involvement in conditioned immunosuppression | Q52302945 | ||
| Antagonism of morphine-induced aversive conditioning by naloxone | Q52313427 | ||
| Noradrenergic sympathetic innervation of the spleen: II. Tyrosine hydroxylase (TH)-positive nerve terminals form synapticlike contacts on lymphocytes in the splenic white pulp | Q69909222 | ||
| Evidence for beta adrenergic receptor involvement in the immunomodulatory effects of morphine | Q70459469 | ||
| Acute electrical stimulation of lateral hypothalamus increases natural killer cell activity in rats | Q71259829 | ||
| Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone | Q72083373 | ||
| Hypothalamic modulation of splenic natural killer cell activity in rats | Q72274883 | ||
| The standardization of NK cell assays for use in studies of biological response modifiers | Q72728197 | ||
| P433 | issue | 1 | |
| P921 | main subject | opioid | Q427523 |
| P304 | page(s) | 89-97 | |
| P577 | publication date | 2007-08-03 | |
| P1433 | published in | Brain, Behavior, and Immunity | Q15716593 |
| P1476 | title | Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation | |
| P478 | volume | 22 |
| Q36971189 | Assessment of individual differences in the rat nucleus accumbens transcriptome following taste-heroin extended access. |
| Q45073147 | CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward |
| Q35676825 | Early-life experience decreases drug-induced reinstatement of morphine CPP in adulthood via microglial-specific epigenetic programming of anti-inflammatory IL-10 expression |
| Q36736335 | Effect of chronic delivery of the Toll-like receptor 4 antagonist (+)-naltrexone on incubation of heroin craving. |
| Q35832263 | Effect of κ-opioid receptor agonist on the growth of non-small cell lung cancer (NSCLC) cells |
| Q34733248 | Effects of fentanyl anesthesia and sufentanil anesthesia on regulatory T cells frequencies |
| Q36948685 | Effects of neonatal stress and morphine on kappa opioid receptor signaling |
| Q42725528 | Effects of neonatal stress and morphine on murine hippocampal gene expression |
| Q39826592 | Endogenous μ-opioid peptides modulate immune response towards malignant melanoma |
| Q33919036 | Intensive Care Unit-acquired infection as a side effect of sedation |
| Q40354737 | Interleukin-1 signaling in the basolateral amygdala is necessary for heroin-conditioned immunosuppression |
| Q47596137 | Morphology of subcortical brain nuclei is associated with autonomic function in healthy humans. |
| Q37707087 | Region-specific contribution of the ventral tegmental area to heroin-induced conditioned immunomodulation |
| Q91585015 | Sufentanil impairs autophagic degradation and inhibits cell migration in NCI-H460 in vitro |
| Q36620596 | Ventral tegmental area-basolateral amygdala-nucleus accumbens shell neurocircuitry controls the expression of heroin-conditioned immunomodulation |
| Q34363541 | Whole-genome expression profile in zebrafish embryos after chronic exposure to morphine: identification of new genes associated with neuronal function and mu opioid receptor expression |
Search more.